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Between March 1983 and July, 1986 a modest clinical trial of whole pancreas 
transplantation was undertaken at the University of Pittsburgh. Followups 
were to 12 May 1988. 
Number of patients: 15 
Mean age (years): 30 
Number of grafts: 16 
Previous kidney transplantation: 7 
Simultaneous kidney transplantation: 5 
Subsequent kidney transplantation: 1 
Deaths less than one year: 3 
Deaths greater than one year: 1 
One year pancreas survival (actual): 50% 
Pancreas lost after one year: 4 
Pancreas functioning (3 to 5 years): 4 
Composite pancreaticoduodenal grafts were used preferentially in our series, 
because they allowed transplantation of all the available pancreatic islets, 
using large vascular and conventional intestinal anastomoses [1, 2]. The blood 
supply was through the donor celiac axis and the superior mesenteric artery of 
the donor which were anastomosed using a common Carrel patch of the donor 
aorta to either the common or external iliac artery of the recipient. Venous 
drainage was through the donor portal vein which was anastomosed to an iliac 
vein of the recipient. The pancreatic secretions were drained into the intestinal 
tract, through a duodenojejunostomy. In 7 of our early cases, the spleen was 
included in the graft: 3 of these patients required allograft splenectomies due 
to the development of graft versus host disease, which manifested itself as 
severe hemolysis, thrombocytopenia and leucopenia (one case each). 
Four of our patients developed mycotic aneurysms of the iliac artery, at the 
site of the Carrel patch. These ruptured, 3 of them into the retroperitoneum 
and one into the jejunum, at the site of the pancreatic graft drainage. The 
ruptures occurred a few days to more than a year after the failed pancreatic 
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grafts had been removed. Surgical treatment required emergency ligation of 
the illiac artery and extraanatomical femorofemoral bypass in all but one. The: 
exceptional patient maintained sufficient blood supply to her lower extremity 
after the common iliac artery was ligated. 
Immunosuppression was with cyclosporin and prednisone. Azathioprine 
and antilymphocyte globulin were used as necessary. 
Although in our series the livers of the pancreas donors were not used for 
transplantation, we have since performed combined liver-pancreas donor oper. 
ations. This is fairly simple in case of segmental pancreatic transplantation, 
provided, there is a single hepatic artery; the splenic artery and vein remain with 
the segment of pancreas and the hepatic artery anatomy remains intact. 
When the total pancreas and liver are harvested together, part of the portal 
vein can be left with the pancreas. The celiac axis can be left with the pancrea.'I 
and the common hepatic or proper hepatic artery can be used for the arterial 
revascularization of the liver. Arterial or venous grafts can be used as needed 
for either the liver or the pancreas. It has been our experience that handling of 
the structures may be equally important as the anatomical considerations if 
inadvertent ischemic injury of either organ is to be avoided. We have been sent 
two dead livers from well meaning members of 2 pancreas teams in other cities. 
Not only were the livers ruined, but both pancreas were discarded eventually. 
A collegeal interaction among the interested teams can usually resolve the 
dilemma of using the one organ in preference to the other, especially as the 
demand for both grafts grows. Technical and judgement matters of the kind 
are discussed elsewhere [2]. 
All of our pancreas recipients except one who had a technical failure, had 
non diabetic glucose tolL-rance tests after transplantation and were able to 
discontinue exogenous insulin treatment. They had high peripheral fasting 
insulin and C-peptide levels. Stimulated values to oral, intravenous and mixed 
meals were normal. 
Retinopathy as evaluated with fundoscopic photos and visual acuity mea-
surements did not improve or became worse during the study period despite 
achievement of a euglycemic state. In contrast, peripheral neuropathy as 
evaluated with nerve conduction studies showed a persistent trend to improve-
ment. Large vessel disease, manifested by P1yocardial infarctions or by compli-
cations of peripheral vascular disease continued to progress. 
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